Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SIGA TECHNOLOGIES INC | Chief Executive Officer, Director | Restricted Stock Units | 168K | $1.02M | $6.07 | Jan 27, 2024 | Direct |
SIGA TECHNOLOGIES INC | Chief Executive Officer, Director | Performance Stock Units | 119K | $895K | $7.55 | Oct 25, 2024 | Direct |
SIGA TECHNOLOGIES INC | Chief Executive Officer, Director | Common Stock, par value $.0001 per share | 35.4K | $240K | $6.77 | Oct 25, 2024 | Direct |
SIGA TECHNOLOGIES INC | Chief Executive Officer, Director | Stock Option (Right to buy) | 219K | Jan 27, 2024 | Direct | ||
Verrica Pharmaceuticals Inc. | Director | Stock Option (right to buy) | 20K | Jun 6, 2024 | Direct | ||
Candel Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 14.2K | Jun 26, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SIGA | SIGA TECHNOLOGIES INC | Oct 25, 2024 | 3 | -$162K | 4 | Oct 29, 2024 | Chief Executive Officer, Director |
CADL | Candel Therapeutics, Inc. | Jun 26, 2024 | 1 | $0 | 4 | Jun 27, 2024 | Director |
VRCA | Verrica Pharmaceuticals Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
SIGA | SIGA TECHNOLOGIES INC | Jan 27, 2024 | 4 | $0 | 4 | Jan 30, 2024 | Chief Executive Officer, Director |
SIGA | SIGA TECHNOLOGIES INC | Jan 27, 2024 | 0 | $0 | 3 | Jan 30, 2024 | Chief Executive Officer, Director |
CADL | Candel Therapeutics, Inc. | Jun 28, 2023 | 1 | $0 | 4 | Jun 29, 2023 | Director |
VRCA | Verrica Pharmaceuticals Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
CADL | Candel Therapeutics, Inc. | Oct 13, 2022 | 1 | $0 | 4 | Oct 17, 2022 | Director |
VRCA | Verrica Pharmaceuticals Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
CADL | Candel Therapeutics, Inc. | Dec 31, 2021 | 1 | $0 | 5/A | Feb 14, 2022 | Director |
CADL | Candel Therapeutics, Inc. | Jul 29, 2021 | 1 | $80K | 4 | Aug 2, 2021 | Director |
CADL | Candel Therapeutics, Inc. | Jul 26, 2021 | 0 | $0 | 3 | Jul 26, 2021 | Director |
VRCA | Verrica Pharmaceuticals Inc. | Jun 10, 2021 | 1 | $0 | 4/A | Jun 17, 2021 | Director |